000 01200 a2200337 4500
005 20250512083838.0
264 0 _c19850917
008 198509s 0 0 eng d
022 _a0022-3565
040 _aNLM
_beng
_cNLM
100 1 _aAbernethy, D R
245 0 0 _aProbenecid impairment of acetaminophen and lorazepam clearance: direct inhibition of ether glucuronide formation.
_h[electronic resource]
260 _bThe Journal of pharmacology and experimental therapeutics
_cAug 1985
300 _a345-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAcetaminophen
_xmetabolism
650 0 4 _aAdult
650 0 4 _aDrug Interactions
650 0 4 _aFemale
650 0 4 _aGlucuronates
_xmetabolism
650 0 4 _aHumans
650 0 4 _aLorazepam
_xmetabolism
650 0 4 _aMale
650 0 4 _aMetabolic Clearance Rate
_xdrug effects
650 0 4 _aMiddle Aged
650 0 4 _aProbenecid
_xpharmacology
700 1 _aGreenblatt, D J
700 1 _aAmeer, B
700 1 _aShader, R I
773 0 _tThe Journal of pharmacology and experimental therapeutics
_gvol. 234
_gno. 2
_gp. 345-9
999 _c4026359
_d4026359